Dr. Hönle AG

EANS-News: Hönle achieves a record result of EUR 0.89 per share

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

annual result

Graefeling/Munich (euro adhoc) - According to preliminary figures, Hönle Group achieved revenue of EUR 54.6 million (PY: EUR 45.0 m.) in financial year 2009/2010. The operating result (EBIT) jumped from EUR -3.9 million in the previous year to EUR 5.5 million in the financial year ended, and the Group result rose from EUR -4.1 million to EUR 4.8 million. The earnings per share amounted to EUR 0.89 (PY: EUR -0.80). In the fourth quarter also, Hönle profits from the economic upswing that has spread to all business segments. Revenue rose from EUR 11.4 million in the previous year´s quarter to EUR 15.6 million in the fourth quarter of the reporting year, and the operating result increased from EUR -1.9 million to EUR 2.6 million in the same period. The Hönle Group´s liquid assets grew in financial year 2009/2010 and came to EUR 6.7 million as at 30 September 2010. The equity capital ratio stood at 69.2 %.

The Dr. Hönle AG Management Board and Supervisory Board intend to have their shareholders participate in the corporate success and will suggest to the General Meeting that a dividend of at least EUR 0.25 per share be paid out.

Outlook: As recently announced, Dr. Hönle AG acquired a 51 % stake in UV-Technik Speziallampen GmbH, Wulmbach, Ilmenau. UV-Technik Speziallampen GmbH has many years of know-how in the segment of UV lamps that are used in the water sterilisation market, in particular. Hönle opens up to a sustainable growth in the life science market.

The Management Board aims at increasing consolidated revenues to EUR 65 million and the operating result (EBIT) to EUR 7.5 million in financial year 2010/211, including the effects of the most recent acquisition.

The sustained economic upswing, which has meanwhile spread to all of Hönle Group´s sales markets, will impact positively on business development. Management assumes that the upturn in the adhesives segment will continue. In the growth market for UV-based digital printing, Hönle expects positive development in the orders position and a revenue increase in financial year 2010/2011. In special equipment engineering which encompasses the fields of sterilisation and sunlight simulation, Management likewise expects positive revenue development. Moreover, Hönle will benefit from the expected pick-up in offset printing and will sell more UV systems than in the past financial year.

About Hönle: Dr. Hönle AG is a listed technology company with registered head office in Gräfelfing, near Munich. With a staff level of about 300 employees, the Hönle Group is one of the world´s leading systems suppliers in the UV technology segment. The equipment and systems are used for drying inks and coatings, curing adhesives and plastics, disinfecting and in the simulation of natural sunlight. The Company´s business activities focus also on the development and sale of industrial adhesives and compounds. The Group is represented by own companies and sales partners worldwide at 50 locations in more than 20 countries.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

Further inquiry note: Peter Weinert Tel.: +49 89 85608 173 E-Mail: peter.weinert@hoenle.de Web: www.hoenle.com

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technology All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              Hannover / free trade
              München / free trade



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: